- Home
- ALDX vs NPWR Comparison
ALDX vs NPWR Comparison
Compare ALDX & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NPWR
- Stock Information
- Founded
- ALDX 2004
- NPWR 2010
- Country
- ALDX United States
- NPWR United States
- Employees
- ALDX N/A
- NPWR N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NPWR Industrial Machinery/Components
- Sector
- ALDX Health Care
- NPWR Energy
- Exchange
- ALDX Nasdaq
- NPWR Nasdaq
- Market Cap
- ALDX 133.7M
- NPWR 148.7M
- IPO Year
- ALDX 2014
- NPWR N/A
- Fundamental
- Price
- ALDX $2.19
- NPWR $1.93
- Analyst Decision
- ALDX Strong Buy
- NPWR Buy
- Analyst Count
- ALDX 2
- NPWR 2
- Target Price
- ALDX $9.50
- NPWR $4.00
- AVG Volume (30 Days)
- ALDX 1.2M
- NPWR 1.3M
- Earning Date
- ALDX 05-14-2025
- NPWR 05-12-2025
- Dividend Yield
- ALDX N/A
- NPWR N/A
- EPS Growth
- ALDX N/A
- NPWR N/A
- EPS
- ALDX N/A
- NPWR N/A
- Revenue
- ALDX N/A
- NPWR $250,000.00
- Revenue This Year
- ALDX N/A
- NPWR $308.00
- Revenue Next Year
- ALDX N/A
- NPWR $1,811.08
- P/E Ratio
- ALDX N/A
- NPWR N/A
- Revenue Growth
- ALDX N/A
- NPWR 100.00
- 52 Week Low
- ALDX $1.14
- NPWR $1.48
- 52 Week High
- ALDX $7.20
- NPWR $14.28
- Technical
- Relative Strength Index (RSI)
- ALDX 38.93
- NPWR 51.60
- Support Level
- ALDX $2.10
- NPWR $1.48
- Resistance Level
- ALDX $2.30
- NPWR $2.63
- Average True Range (ATR)
- ALDX 0.15
- NPWR 0.25
- MACD
- ALDX 0.06
- NPWR 0.10
- Stochastic Oscillator
- ALDX 37.93
- NPWR 46.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.